---
schema_version: "secwatch.filing_event.v1"
accession: "0001124140-24-000051"
form_type: "8-K"
ticker: null
cik: "0001124140"
company_name: "EXACT SCIENCES CORP"
filed_at: "2024-06-03T23:59:59+00:00"
generated_at: "2026-06-01T06:43:39.523134+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Exact Sciences CCO Everett Cunningham departs; reaffirms Q2 and FY 2024 guidance

## Summary
- Chief Commercial Officer Everett Cunningham departing June 13, 2024 for a non-competing opportunity.
- Commercial organization reorganized under Screening and Precision Oncology teams; GMs Orville and Baranick continue.
- Reaffirmed Q2 2024 total revenue guidance of $677-697M; Screening $522-532M, Precision Oncology $155-165M.
- Reaffirmed full-year 2024 total revenue $2.810-2.850B and adjusted EBITDA $325-350M.

## SEC filing metadata
- accession: 0001124140-24-000051
- form_type: 8-K
- cik: 0001124140
- company_name: EXACT SCIENCES CORP
- filed_at: 2024-06-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1124140/000112414024000051/0001124140-24-000051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1124140/000112414024000051/exas-20240530.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001124140-24-000051
- JSON: https://secwatch.observer/filing/0001124140-24-000051.json
- Plain text: https://secwatch.observer/filing/0001124140-24-000051.txt

## Key facts
- Executive change
  Everett Cunningham departed as Chief Commercial Officer at EXACT SCIENCES CORP.
  - Action: departing
  - Role: Chief Commercial Officer
  source text: Exact Sciences also reported that on May 30, 2024, Everett Cunningham, Chief Commercial Officer, informed the Company that effective on June 13, 2024 he will be departing for an opportunity with an organization that does not compete with the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1124140/000112414024000051/0001124140-24-000051-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.